Source: Annual Congress 2010 - Innovations in the assessment of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Mohamed, A. Khafagy, A. E. Saad, N. Abdelaty, N. Moustafa (Ismailia, Egypt). Serum hyaluronate: A new biomarker of passive smoking-induced lung injury in asthmatic patients. Eur Respir J 2010; 36: Suppl. 54, 4608

Member's Comments

No comment yet.

Related content which might interest you: Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016 Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease. Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Serum heat shock protein 47 levels in patients with drug induced lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003 Total desmosines in plasma and urine correlate with lung function Source: Eur Respir J 2012; 39: 839-845 Year: 2012 Airway obstruction and or emphysema shows a different plasma inflammatory response in asymptomatic smokers or ex-smokers participating in a lung cancer screening program Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012